---
title: "AYTU: EXXUA launch drove $6.6M in revenue, but overall sales fell 13% and net loss reached $14.3M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299809437.md"
description: "Fiscal 2026 saw a strategic pivot to EXXUA, generating $6.6M in its launch year, while overall net revenue declined 13.3% to $57.6M due to reduced focus on ADHD and Pediatric portfolios and increased generic competition. Net loss was $14.3M, with continued investment in EXXUA and CNS products.Original document: Aytu BioPharma, Inc. [AYTU] SEC 10-K Annual Report — Sep. 22 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-22T20:20:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299809437.md)
  - [en](https://longbridge.com/en/news/299809437.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299809437.md)
generator: "portal-rs"
---

# AYTU: EXXUA launch drove $6.6M in revenue, but overall sales fell 13% and net loss reached $14.3M

Fiscal 2026 saw a strategic pivot to EXXUA, generating $6.6M in its launch year, while overall net revenue declined 13.3% to $57.6M due to reduced focus on ADHD and Pediatric portfolios and increased generic competition. Net loss was $14.3M, with continued investment in EXXUA and CNS products.

Original document: Aytu BioPharma, Inc. \[AYTU\] SEC 10-K Annual Report — Sep. 22 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [AYTU.US](https://longbridge.com/en/quote/AYTU.US.md)

## Related News & Research

- [Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales](https://longbridge.com/en/news/299809035.md)
- [AYTU: EXXUA launch drives growth in CNS therapeutics, with FY26 revenue at $66.4M](https://longbridge.com/en/news/299813775.md)
- [Vylor has scarcity value, says Jim Cramer](https://longbridge.com/en/news/300833366.md)
- [McGrath RentCorp director Joseph F. Hanna disposes of 7,500 common shares worth $862,824.75](https://longbridge.com/en/news/300833509.md)
- [Constellation Brands Stock Forecast: Beer Demand Faces a Key Q2 Earnings Test](https://longbridge.com/en/news/300859275.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**